Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.30
+0.22 (1.68%)
At close: Mar 6, 2026, 4:00 PM EST
13.42
+0.12 (0.90%)
After-hours: Mar 6, 2026, 6:26 PM EST
Trevi Therapeutics Employees
Trevi Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,348,765
Market Cap
1.71B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Agios Pharmaceuticals | 540 |
| Ardelyx | 489 |
| Intellia Therapeutics | 377 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Nuvation Bio | 291 |
| Innoviva | 159 |
TRVI News
- 5 days ago - Trevi Therapeutics to Participate in Upcoming March Conferences - GlobeNewsWire
- 18 days ago - Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 6 weeks ago - Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA) - PRNewsWire
- 2 months ago - Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference - PRNewsWire
- 3 months ago - Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer - PRNewsWire
- 3 months ago - Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond - Seeking Alpha
- 4 months ago - Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire